** LIMITED TIME DEAL ** Free Shipping on ALL orders in the USA

Studies have found that menopausal hormone therapy like EstroCap may cut UTI risk.

Postmenopausal women taking estrogen therapy may be more resistant to recurrent urinary tract infections (UTI), according to new research presented at the European Association of Urology 2020 virtual congress.

Changes in the bacteria of the urinary tract after a UTI may lead to less bacterial diversity, which can cause postmenopausal women to recurrent UTI infections. Nicole De Nisco, PhD, of the University of Texas at Dallas and colleagues reported. The “never UTI” and “remittent UTI” groups also displayed disparate levels of putatively protective (eg, Lactobacillus crispatus) and nonprotective (eg, L inners) species.

Women taking estrogen therapy [like EstroCap] had high levels of Lactobacilli in their urine.

In contrast, women not taking supplemental estrogen or with naturally low estrogen had low or undetectable levels.

Estrogen possibly supports the growth of Lactobacillus in the uterine tract, Dr Nisco suggested. Women receiving hormone replacement therapy via a patch or pill [like EstroCap} had more Lactobacillus than those receiving it via vaginal cream, she reported.

“We now need to look more closely at whether managing the bacterial content of the urogenital system might affect susceptibility to infection,” Dr. Nisco stated in a news release.

Lactobacilli are known to play a protective role against vaginal infections, and this function may be conserved in the urogenital tract.

“If Lactobacillus really can help with UTIs, development of a probiotic to use in conjunction with [menopausal hormone therapy] may avoid antibiotic use in these women, but this needs to be tested.”

Women taking estrogen therapy [like EstroCap] had high levels of Lactobacilli in their urine.

References:

Neugent M, Hulyalkar N, Kumar A, et al. Metagenomic analysis of the genitourinary microbiome of postmenopausal women with recurrent UTI. Presented at: EAU20 Virtual Congress; July 17 to 19, 2020. Abstract 84.
Women taking menopausal hormone therapy may be more resistant to urine infections [press release]. Amsterdam, The Netherlands. Europa Uomo & European Association of Urology congress; July 18, 2020.

This article originally appeared on Renal and Urology News

This website provides general educational information. It is not intended to be, and should not be used as, a substitute for medical treatment by a health care professional. We are not making a diagnosis of your condition or a recommendation about the course of treatment for your particular circumstances. You should never disregard or delay seeking medical advice because of what you have read on this website.